Veeva Systems Inc Unsponsored Brazilian Depositary Receipt Repr 0.0333 Sh -A- (V2EE34) Stock Price & Analysis

V2EE34 Stock Chart & Stats

R$56.30-R$0.10(-0.18%)

At close: Oct 30

Day’s Range: BRL 55.92 - BRL 56.30
52-Week Range: BRL 23.00 - BRL 57.11
Previous Close: BRL 56.40
Volume: N/A
Average Volume (3M): 1,548
Market Cap: BRL 275.49B
Enterprise Value: BRL 120.11B
Total Cash (Recent Filing): N/A
Total Debt (Recent Filing): N/A
Price to Earnings (P/E): 53043.2
Beta: -0.40
Next Earnings: Nov 26, 2026 (Est.)
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

Veeva Systems Inc Unsponsored Brazilian Depositary Receipt Repr 0.0333 Sh -A- News

Veeva price target raised to $345 from $280 at Mizuho

Mizuho raised the firm’s price target on Veeva (VEEV) to $345 from $280 and keeps an Outperform rating on the shares. Published first on TheFly – the ultimate source for

4d agoVEEV VEE

Veeva price target raised to $375 from $360 at Barclays

Barclays raised the firm’s price target on Veeva (VEEV) to $375 from $360 and keeps an Overweight rating on the shares. Published first on TheFly – the ultimate source for

5d agoVEEV VEE

Veeva price target raised to $350 from $300 at Baird

Baird raised the firm’s price target on Veeva (VEEV) to $350 from $300 and keeps an Outperform rating on the shares. Published first on TheFly – the ultimate source for

1w agoVEEV VEE

Veeva Systems: Strong Life Sciences AI Position but Execution Risks Keep Rating at Hold and Price Target Unchanged at $275

Analyst Craig Hettenbach from Morgan Stanley maintained a Hold rating on Veeva Systems and keeping the price target at $275.00. Craig Hettenbach has given his Hold rating due to a

1w agoVEEV VEE

OpenAI confirms acquisition of biopharma platform Orchestra Bio

OpenAI confirmed it has acquired Orchestra Bio, a “platform that helps biopharma teams coordinate the complex process of drug development.” OpenAI added, “We’re bringing Orchestra’s team and technology together with

1w agoVEEV VEE

Veeva moves lower after report says OpenAI buying Orchestra Bio

Veeva (VEEV) shares moved off their session highs after Axios reported that OpenAI has acquired Orchestra Bio, a startup building AI agents to help pharmaceutical companies manage drug development. Published

1w agoVEEV VEE

Veeva price target raised to $360 from $315 at Barclays

Barclays raised the firm’s price target on Veeva (VEEV) to $360 from $315 and keeps an Overweight rating on the shares after hosting meetings with management. The firm left feeling

2w agoVEEV VEE

Iqvia selects Veeva clinical operations applications

IQVIA (IQV) and Veeva Systems (VEEV) announced an expansion of their partnership with the selection of Veeva CTMS, eTMF, Study Startup, and Site Connect as enterprise standard applications that will

2w agoIQV VEEV

Midday Fly By: Micron earnings beat, MSG Sports approves Rangers spinoff

The major averages were lower near noon to start the month as rising Treasury yields continue to weigh on markets even as Micron reported upbeat Q4 earnings and revenue. Also

1M agoBP MU

Veeva supporting transformation of medicine through AI, Barron’s reports

AI holds the promise to accelerate drug development, optimize clinical trials, and bring lifesaving therapies to market faster, and Veeva (VEEV) Systems is making that transformation happen, Barrons’ Dan Victor

1M agoVEEV VEE

Veeva rallies after announcing new ‘top 20’ biopharma customer

Veeva (VEEV) announced this morning a new “top 20” biopharma commitment, adding to recent selections by Amgen, Biogen, Eli Lilly, and Regeneron. “With more than 190 live customers and global

1M agoVEEV VEE

AI-Driven Upside Spurs Stan Berenshteyn to Reiterate Buy on Veeva and Raise Price Target from $320 to $330

In a report released on September 6, Stan Berenshteyn from Wells Fargo reiterated a Buy rating on Veeva Systems, with a price target of $330.00. Stan Berenshteyn has given his

1M agoVEEV VEE

Veeva Price Target Raised to $275 on Strong Q2 and Guidance, but AI Uncertainties Keep Rating at Hold

Craig Hettenbach, an analyst from Morgan Stanley, maintained the Hold rating on Veeva Systems. The associated price target was raised to $275.00. Craig Hettenbach has given his Hold rating due

2M agoVEEV VEE

Veeva Gets Buy Rating as Revenue Reaccelerates, Guidance Rises and AI-Driven Life Sciences Moat Widens

William Blair analyst Dylan Becker has maintained their bullish stance on VEEV stock, giving a Buy rating today. Dylan Becker has given his Buy rating due to a combination of

2M agoVEEV VEE

V2EE34 FAQ

What was Veeva Systems Inc Unsponsored Brazilian Depositary Receipt Repr 0.0333 Sh -A-’s price range in the past 12 months?

Veeva Systems Inc Unsponsored Brazilian Depositary Receipt Repr 0.0333 Sh -A- lowest stock price was R$23.00 and its highest was R$57.11 in the past 12 months.

What is Veeva Systems Inc Unsponsored Brazilian Depositary Receipt Repr 0.0333 Sh -A-’s market cap?

Veeva Systems Inc Unsponsored Brazilian Depositary Receipt Repr 0.0333 Sh -A-’s market cap is R$275.49B.

When is Veeva Systems Inc Unsponsored Brazilian Depositary Receipt Repr 0.0333 Sh -A-’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Veeva Systems Inc Unsponsored Brazilian Depositary Receipt Repr 0.0333 Sh -A-’s earnings last quarter?

Veeva Systems Inc Unsponsored Brazilian Depositary Receipt Repr 0.0333 Sh -A- released its earnings results on Aug 26, 2026. The company reported R$0 earnings per share for the quarter.

Is Veeva Systems Inc Unsponsored Brazilian Depositary Receipt Repr 0.0333 Sh -A- overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Veeva Systems Inc Unsponsored Brazilian Depositary Receipt Repr 0.0333 Sh -A- pay dividends?

Veeva Systems Inc Unsponsored Brazilian Depositary Receipt Repr 0.0333 Sh -A- does not currently pay dividends.

What is Veeva Systems Inc Unsponsored Brazilian Depositary Receipt Repr 0.0333 Sh -A-’s EPS estimate?

Veeva Systems Inc Unsponsored Brazilian Depositary Receipt Repr 0.0333 Sh -A-’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Veeva Systems Inc Unsponsored Brazilian Depositary Receipt Repr 0.0333 Sh -A- have?

Veeva Systems Inc Unsponsored Brazilian Depositary Receipt Repr 0.0333 Sh -A- has 4,862,127,400 shares outstanding.

What happened to Veeva Systems Inc Unsponsored Brazilian Depositary Receipt Repr 0.0333 Sh -A-’s price movement after its last earnings report?

Veeva Systems Inc Unsponsored Brazilian Depositary Receipt Repr 0.0333 Sh -A- reported an EPS of R$0 in its last earnings report. Following the earnings report the stock price went up 13.748%.

Which hedge fund is a major shareholder of Veeva Systems Inc Unsponsored Brazilian Depositary Receipt Repr 0.0333 Sh -A-?

Currently, no hedge funds are holding shares in BR:V2EE34

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Veeva Systems Inc Unsponsored Brazilian Depositary Receipt Repr 0.0333 Sh -A- (V2EE34) Earnings & Revenues

Historic Earnings Reports

Technical Analysis

Overall Consensus

Indicator	Bullish	Bearish
Overall Consensus	14	8
Technical Analysis	3	7
Moving Averages	11	1

Technical Analysis >

Similar Stocks

Stocks similar to BR:V2EE34
Company	Price & Change	Follow
BR:A1GI34Agilent Technologies, Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 1/2 Sh
BR:I1LM34Illumina, Inc. Unsponsored Brazilian Depositary Receipt Repr 0.2 Sh
BR:I1QV34IQVIA Holdings Inc Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh
BR:L1CA34Labcorp Holdings Inc. Shs Unsponsored Brazilian Depositary Receipt Repr 0.25 Sh
BR:WATC34Waters Corporation Shs Unsponsored Brazilian Depository Receipt Repr 1/4 Sh

Compare BR:V2EE34 Stocks >

Popular Stocks

Popular Stocks
Company	Price & Change	Follow
NVDANvidia
AAPLApple
MSFTMicrosoft

V2EE34 Stock Chart & Stats

Veeva Systems Inc Unsponsored Brazilian Depositary Receipt Repr 0.0333 Sh -A- News

Veeva price target raised to $345 from $280 at Mizuho

Veeva price target raised to $375 from $360 at Barclays

Veeva price target raised to $350 from $300 at Baird

Veeva Systems: Strong Life Sciences AI Position but Execution Risks Keep Rating at Hold and Price Target Unchanged at $275

OpenAI confirms acquisition of biopharma platform Orchestra Bio

Veeva moves lower after report says OpenAI buying Orchestra Bio

Veeva price target raised to $360 from $315 at Barclays

Iqvia selects Veeva clinical operations applications

Midday Fly By: Micron earnings beat, MSG Sports approves Rangers spinoff

Veeva supporting transformation of medicine through AI, Barron’s reports

Veeva rallies after announcing new ‘top 20’ biopharma customer

AI-Driven Upside Spurs Stan Berenshteyn to Reiterate Buy on Veeva and Raise Price Target from $320 to $330

Veeva Price Target Raised to $275 on Strong Q2 and Guidance, but AI Uncertainties Keep Rating at Hold

Veeva Gets Buy Rating as Revenue Reaccelerates, Guidance Rises and AI-Driven Life Sciences Moat Widens

V2EE34 FAQ

Veeva Systems Inc Unsponsored Brazilian Depositary Receipt Repr 0.0333 Sh -A- (V2EE34) Earnings & Revenues

Technical Analysis

Overall Consensus

Similar Stocks

Popular Stocks

Become an Expert with TipRanks Premium